Routine testing (n = 10) | Targeted testing (n = 4) | p | |
---|---|---|---|
Age groups (years) | |||
18–25 | 1 | 0 | 0.63 |
26–35 | 4 | 2 | |
36–45 | 1 | 2 | |
46–55 | 2 | 0 | |
56–65 | 2 | 0 | |
Gender | |||
Male, n (%) | 5 (50%) | 4 (100%) | 0.22 |
Female, n (%) | 5 (50%) | 0 | |
Transmission group, n (%) | |||
Intravenous drug usage | 2 (20%) | 1 (25%) | 0.041 |
Heterosexual | 8 (80%) | 1 (25%) | |
Men who have sex with men | 0 | 2 (50%) | |
Disease stage, n (%) | |||
CD4 count < 200/mm3 | 2 (20%) | 4 (100%) | 0.031 |
CD4 count 200–350/mm3 | 3 (30%) | 0 | |
CD4 count > 350/mm3 | 5 (50%) | 0 | |
CD4 cell count: | |||
Min | 65 | 58 | 0.088 |
Max | 771 | 137 | |
Median | 413.5 | 95 | |
Interquartile range | 360 | 71.5 | |
Patients for whom HIV positive contacts were detected, n (%) | 3 (30%) | 1 (25%) | 0.999 |